News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
van Dijk Marcus Antonius
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/12/2023 |
4
| van Dijk Marcus Antonius (Chief Scientific Officer) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 51,628 shares
@ $2.32, valued at
$119.8k
Paid exercise price by delivering 24,265 shares
@ $2.32, valued at
$56.3k
|
|
| 01/11/2023 |
4
| van Dijk Marcus Antonius (Chief Scientific Officer) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 15,000 options
@ $2.32, valued at
$34.8k
|
|
| 01/25/2022 |
4
| van Dijk Marcus Antonius (Chief Technology Officer) has filed a Form 4 on MiNK Therapeutics, Inc.|
Txns:
| Granted 62,500 options to buy
@ $3.12, valued at
$195k
|
|
| 10/20/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|